XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated statements of stockholders' equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Balance at Dec. 31, 2022 $ 184,849 $ 4 $ 483,170 $ (1,175) $ (297,150)
Balance, Shares at Dec. 31, 2022   39,439,575      
Net loss (22,545)       (22,545)
Unrealized gain on marketable securities 577     577  
Stock-based compensation 5,887   5,887    
Issuance of common stock upon exercise of stock options 158   158    
Issuance of common stock upon exercise of stock options, Shares   80,611      
Issuance of common stock related to employee stock purchase plan 153   153    
Issuance of common stock related to employee stock purchase plan, Shares   19,550      
Shares sold as part of controlled equity offering sales agreement 44,743   44,743    
Shares sold as part of controlled equity offering sales agreement, Shares   4,635,353      
Balance at Mar. 31, 2023 213,822 $ 4 534,111 (598) (319,695)
Balance, Shares at Mar. 31, 2023   44,175,089      
Balance at Dec. 31, 2022 184,849 $ 4 483,170 (1,175) (297,150)
Balance, Shares at Dec. 31, 2022   39,439,575      
Net loss (77,741)        
Unrealized gain on marketable securities 1,028        
Balance at Sep. 30, 2023 172,999 $ 4 548,033 (147) (374,891)
Balance, Shares at Sep. 30, 2023   44,293,115      
Balance at Mar. 31, 2023 213,822 $ 4 534,111 (598) (319,695)
Balance, Shares at Mar. 31, 2023   44,175,089      
Net loss (30,654)       (30,654)
Unrealized gain on marketable securities 219     219  
Stock-based compensation 6,760   6,760    
Issuance of common stock upon exercise of stock options 48   48    
Issuance of common stock upon exercise of stock options, Shares   27,908      
Balance at Jun. 30, 2023 190,195 $ 4 540,919 (379) (350,349)
Balance, Shares at Jun. 30, 2023   44,202,997      
Net loss (24,542)       (24,542)
Unrealized gain on marketable securities 232     232  
Stock-based compensation 6,552   6,552    
Issuance of common stock upon exercise of stock options 161   161    
Issuance of common stock upon exercise of stock options, Shares   38,197      
Issuance of common stock related to employee stock purchase plan 401   401    
Issuance of common stock related to employee stock purchase plan, Shares   51,921      
Balance at Sep. 30, 2023 172,999 $ 4 548,033 (147) (374,891)
Balance, Shares at Sep. 30, 2023   44,293,115      
Balance at Dec. 31, 2023 159,565 $ 5 561,433 (24) (401,849)
Balance, Shares at Dec. 31, 2023   45,918,233      
Net loss (26,374)       (26,374)
Unrealized gain on marketable securities 24     24  
Stock-based compensation 5,410   5,410    
Issuance of common stock upon exercise of stock options 250   250    
Issuance of common stock upon exercise of stock options, Shares   270,032      
Issuance of common stock related to employee stock purchase plan 168   168    
Issuance of common stock related to employee stock purchase plan, Shares   37,542      
Shares sold as part of controlled equity offering sales agreement 1,299   1,299    
Shares sold as part of controlled equity offering sales agreement, Shares   272,270      
Balance at Mar. 31, 2024 140,342 $ 5 568,560   (428,223)
Balance, Shares at Mar. 31, 2024   46,498,077      
Balance at Dec. 31, 2023 159,565 $ 5 561,433 (24) (401,849)
Balance, Shares at Dec. 31, 2023   45,918,233      
Net loss (78,499)        
Unrealized gain on marketable securities 190        
Balance at Sep. 30, 2024 232,113 $ 5 712,290 166 (480,348)
Balance, Shares at Sep. 30, 2024   52,941,191      
Balance at Mar. 31, 2024 140,342 $ 5 568,560   (428,223)
Balance, Shares at Mar. 31, 2024   46,498,077      
Net loss (25,695)       (25,695)
Unrealized gain on marketable securities (15)     (15)  
Stock-based compensation 7,427   7,427    
Issuance of common stock upon exercise of stock options 766   766    
Issuance of common stock upon exercise of stock options, Shares   252,007      
Issuance of common stock upon follow-on offering, net of underwriting discounts, commissions and offering costs 119,884   119,884    
Issuance of common stock upon follow-on offering, net of underwriting discounts, commissions and offering costs, Shares   5,555,557      
Balance at Jun. 30, 2024 242,709 $ 5 696,637 (15) (453,918)
Balance, Shares at Jun. 30, 2024   52,305,641      
Net loss (26,430)       (26,430)
Unrealized gain on marketable securities 181     181  
Stock-based compensation 7,494   7,494    
Issuance of common stock upon exercise of stock options 139   139    
Issuance of common stock upon exercise of stock options, Shares   52,751      
Issuance of common stock related to employee stock purchase plan 364   364    
Issuance of common stock related to employee stock purchase plan, Shares   73,099      
Shares sold as part of controlled equity offering sales agreement 7,656   7,656    
Shares sold as part of controlled equity offering sales agreement, Shares   509,700      
Balance at Sep. 30, 2024 $ 232,113 $ 5 $ 712,290 $ 166 $ (480,348)
Balance, Shares at Sep. 30, 2024   52,941,191